Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
Haartmaninkatu 4, Building 14, Helsinki, Southern Finland, 00290, Finland
LS CancerDiag Ltd is committed to reducing cancer mortality rates with a simple and accurate diagnostic method for inherited MMR deficiency. The MMR deficiency is associated to Lynch syndrome, the world’s most common inherited cancer predisposition. Our vision is to make DiagMMR® the new global standard test for Lynch cancer syndrome diagnosis, and support the early detection of the disease even before tumors develop.
LS CancerDiag DiagMMR is a predictive diagnostic tool that enables preventive follow-up and counseling for affected mutation carriers who are at high risk for developing Lynch syndrome-related …
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 3, 2024 at 11:31am